Peter Marks

FDA Authorizes Pfizer Booster for Kids 5 to 11, Bypasses Advisory Panel

The U.S. Food and Drug Administration (FDA) today authorized a booster dose of the Pfizer-BioNTech COVID-19 vaccine for children ages 5 to 11, without convening its vaccine advisory panel of independent experts to discuss Pfizer’s data on 5- to 11-year-olds — and based on a study subset of only 67 children, CNBC reported.

COVID Vaccines for Kids Under 6 Won’t Have to Meet 50% Efficacy Standard, FDA Official Says

The U.S. Food and Drug Administration’s (FDA) top vaccine official told a congressional committee on Friday that COVID-19 vaccines for kids under 6 will not have to meet the agency’s 50% efficacy threshold required to obtain Emergency Use Authorization (EUA).

FDA Restricts J&J COVID Vax Due to ‘Life-Threatening’ Side Effects

The vaccine was found to cause potentially fatal blood clots.

6 Double Standards Public Health Officials Used to Justify COVID Vaccines

We are not only in an epidemiological crisis, we also are in an epistemological crisis.

Pfizer Pushes for 4th Shot, Says 3 Doses ‘Not That Good’ Against Infections

Pfizer CEO Albert Bourla on Sunday said the vaccine maker plans to submit data on a fourth dose of its COVID-19 vaccine to the U.S. Food and Drug Administration because protection after three doses is “not that good against infections” and “doesn’t last very long” when faced with a variant like Omicron.

Documents Reveal Feds Paid News Outlets to Praise COVID Vaccines

'Corporate media' bought off, and 'the consequence is that many people have needlessly suffered'

U.S. Agencies Quietly Studying Reports of Post-Vax Neurological Issues

FDA, NIH have studying neurological problems in people who've received COVID-19 vaccines.

FDA Postpones Decision on Pfizer COVID-19 Vaccine for Young Children

U.S. drug regulators on Feb. 11 announced they are pushing back a decision on whether to authorize  Pfizer’s COVID-19 vaccine for children as young as 6 months old.

Latest news

- Advertisement -spot_img